Astrana Average Receivables from 2010 to 2026
| ASTH Stock | 18.16 0.87 4.57% |
Average Receivables | First Reported 2010-12-31 | Previous Quarter 70.4 M | Current Value 46.8 M | Quarterly Volatility 19.2 M |
Check Astrana Health financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Astrana Health's main balance sheet or income statement drivers, such as Interest Expense of 40 M, Other Operating Expenses of 2.3 B or Operating Income of 107.9 M, as well as many indicators such as Price To Sales Ratio of 1.18, Dividend Yield of 0.0029 or PTB Ratio of 2.45. Astrana financial statements analysis is a perfect complement when working with Astrana Health Valuation or Volatility modules.
Astrana | Average Receivables | Build AI portfolio with Astrana Stock |
The Average Receivables trend for Astrana Health offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Astrana Health is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.
Latest Astrana Health's Average Receivables Growth Pattern
Below is the plot of the Average Receivables of Astrana Health over the last few years. It is Astrana Health's Average Receivables historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Astrana Health's overall financial position and show how it may be relating to other accounts over time.
| Average Receivables | 10 Years Trend |
|
Average Receivables |
| Timeline |
Astrana Average Receivables Regression Statistics
| Arithmetic Mean | 55,029,542 | |
| Geometric Mean | 52,023,423 | |
| Coefficient Of Variation | 34.90 | |
| Mean Deviation | 18,165,242 | |
| Median | 38,788,196 | |
| Standard Deviation | 19,202,948 | |
| Sample Variance | 368.8T | |
| Range | 39.4M | |
| R-Value | 0.72 | |
| Mean Square Error | 190.9T | |
| R-Squared | 0.51 | |
| Significance | 0 | |
| Slope | 2,727,906 | |
| Total Sum of Squares | 5900.1T |
Astrana Average Receivables History
About Astrana Health Financial Statements
Investors use fundamental indicators, such as Astrana Health's Average Receivables, to determine how well the company is positioned to perform in the future. Although Astrana Health's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
| Last Reported | Projected for Next Year | ||
| Average Receivables | 70.4 M | 46.8 M |
Currently Active Assets on Macroaxis
| FSLY | Fastly Class A | |
| MOB | Mobilicom Limited American | |
| CMG | Chipotle Mexican Grill | |
| CSAN | Cosan SA ADR | |
| RKT | Rocket Companies |
Check out the analysis of Astrana Health Correlation against competitors. For more detail on how to invest in Astrana Stock please use our How to Invest in Astrana Health guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is there potential for Health Care Providers & Services market expansion? Will Astrana introduce new products? Factors like these will boost the valuation of Astrana Health. If investors know Astrana will grow in the future, the company's valuation will be higher. Understanding fair value requires weighing current performance against future potential. All the valuation information about Astrana Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.98) | Earnings Share 0.19 | Revenue Per Share | Quarterly Revenue Growth 0.997 | Return On Assets |
The market value of Astrana Health is measured differently than its book value, which is the value of Astrana that is recorded on the company's balance sheet. Investors also form their own opinion of Astrana Health's value that differs from its market value or its book value, called intrinsic value, which is Astrana Health's true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Astrana Health's market value can be influenced by many factors that don't directly affect Astrana Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Astrana Health's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Astrana Health represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Astrana Health's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.